Log In
Print this Print this

Vapendavir (BTA798)

Also known as: BTA-798

  Manage Alerts
Collapse Summary General Information
Company Aviragen Therapeutics Inc.
DescriptionOral human rhinovirus (HRV) antiviral
Molecular Target HRV capsid
Mechanism of ActionCapsid inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationViral infection
Indication DetailsTreat and prevent human rhinovirus (HRV) infection; Treat human rhinovirus (HRV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today